Interpretation of the 2019 Guidelines for the Management of retinal vein occlusion by the EURETINA

Authors: Chen Lulu,  Chen Youxin

DOI: 10.3760/cma.j.issn.2095-0160.2020.01.012
Published 2020-01-10
Cite as Chin J Exp Ophthalmol, 2020,38(01): 60-63.

Abstract

Retinal vein occlusion(RVO) is the second common retinal vascular disease after diabetic retinopathy.The Management of Retinal Vein Occlusion-Consensus Document published in 2011 gave a comprehensive explanation of RVO diagnosis and treatment.While the European Society of Retina Specialists (EURETINA) updated the guideline for the management of RVO based on the 2011 consensus in August 2019.The current guideline summarized the latest clinical studies, and standardized the diagnosis and treatment of RVO based on stronger evidence-level data.The 2019 guidelines used the Rationale-Evidence-Recommendation structure to provide a comprehensive summary of RVO.

Key words:

Retinal vein occlusion; Diagnosis and treatment; Guideline interpret

Contributor Information

Chen Lulu
Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences, Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College, Beijing 100730, China
Chen Youxin
(Read 315 times, 1 visits today)
Updated: March 17, 2020 — 8:28 am